Regenxbio Shares Rise After New Director's Stock Purchase
Regenxbio (RGNX) saw its stock rise by approximately 3% in early Friday trading following a significant purchase of shares by newly appointed director Gregory Austin Ciongoli. According to an SEC filing, Ciongoli acquired more than 102,000 shares valued at over $949,000 between August and the time of the report. The largest portion of his purchases occurred on Aug. 26 when he bought 49,196 shares at an average price per share that contributed to a total value exceeding $949,000 for all transactions attributed to him in this period.
Tickers: $RGNX
Topics: Gregory Austin Ciongoli Regenxbio SEC filing share purchase